BEUDAMED
    752 results · 21ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    Test, Anti-Tumor Cell Susceptibility

    FDA classification
    FDA Class 3 ·Test, Anti-Tumor Cell Susceptibility

    Sensor, Electro-Optical (For Cervical Cancer)

    FDA classification
    FDA Class 3 ·Sensor, Electro-Optical (For Cervical Cancer)

    Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis

    FDA classification
    FDA Class 3 ·Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis

    Mechanical And Enzymatic Autologous Skin Processor For Cell Suspension, With Applicator

    FDA classification
    FDA Class 3 ·Mechanical And Enzymatic Autologous Skin Processor For Cell Suspension, With Applicator

    Mechanical And Enzymatic Autologous Skin Processor For Cell Suspension, For Stable Vitiligo, With Applicator

    FDA classification
    FDA Class 3 ·Mechanical And Enzymatic Autologous Skin Processor For Cell Suspension, For Stable Vitiligo, With Applicator

    Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer

    FDA classification
    FDA Class 3 ·Electrical Tumor Treatment Fields For Non-Small Cell Lung Cancer

    Whole Blood Pre-Treatment T-Cell Enrichment Reagent

    FDA classification
    FDA Class 3 ·Whole Blood Pre-Treatment T-Cell Enrichment Reagent

    Mycobacterium Tuberculosis, Cell Mediated Immune Response, Enzyme-Linked Immunospot Test

    FDA classification
    FDA Class 3 ·Mycobacterium Tuberculosis, Cell Mediated Immune Response, Enzyme-Linked Immunospot Test

    Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma

    FDA classification
    FDA Class 3 ·Separator For Therapeutic Purposes, Membrane Automated Blood Cell/Plasma

    Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement

    FDA classification
    FDA Class 3 ·Fluorescence In Situ Hybridization, Anaplastic Lymphoma Kinase, Gene Rearrangement

    Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence

    FDA classification
    FDA Class 3 ·Test, Fluorescence In Situ Hybridization (Fish), For Bladder Cancer Detection And Monitoring For Recurrence

    Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor

    FDA classification
    FDA Class 3 ·Immunohistochemistry Assay, Antibody, Epidermal Growth Factor Receptor